Founded in Oct. 31. 2000, EnzyTech, Ltd. Is preparing the production and the sale of chiral intermediates after completing process development. The main business field is related to medicine, EnzyTech Ltd. The biotechnology company, produces the chiral pharmaceutical intermediates using biocatalyst.

The biochemical engineering field is the core business field in the 21st century. In particular, the pharmaceutical industry is an important part that increases more rapidly comparing to other industry.

Enzytech promotes the business of chiral intermediates and active pharmaceutical ingredients using chirotechnology that is developed and protected by our patents.

The chiral pharmaceuticals are high value-added materials and are made of optically active isomers. EnzyTech has secured the various technologies(fusion of bioprocess and organic synthesis) for the production of chiral intermediates and active pharmaceutical ingredients.

We aim to produce and commercialize the chiral intermediates and active pharmaceutical ingredients.

EnzyTech will be a professional company in the biochemical science area, and lead the chiral pharmaceutical industry.